Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care

J Thorac Oncol. 2023 Aug;18(8):986-989. doi: 10.1016/j.jtho.2023.05.003.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Humans
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / therapy
  • Radiosurgery*
  • Standard of Care